Shanghai Aohua Photoelectricity Endoscope And 2 Other Growth Companies With Strong Insider Ties In China

Amidst a backdrop of fluctuating global markets, Chinese stocks have shown resilience, buoyed by strong export figures and strategic economic policies. In this environment, companies like Shanghai Aohua Photoelectricity Endoscope Co., which exhibit high insider ownership, can offer unique advantages through aligned interests between shareholders and management.

Top 10 Growth Companies With High Insider Ownership In China

Name	Insider Ownership	Earnings Growth
Ningbo Sunrise Elc TechnologyLtd (SZSE:002937)	24.3%	27.7%
ShenZhen Woer Heat-Shrinkable MaterialLtd (SZSE:002130)	19%	27.9%
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)	24%	22.3%
Anhui Huaheng Biotechnology (SHSE:688639)	31.4%	28.4%
KEBODA TECHNOLOGY (SHSE:603786)	12.8%	25.1%
Arctech Solar Holding (SHSE:688408)	38.7%	25.8%
Cubic Sensor and InstrumentLtd (SHSE:688665)	10.1%	34.3%
Suzhou Sunmun Technology (SZSE:300522)	36.5%	63.4%
Sineng ElectricLtd (SZSE:300827)	36.5%	39.8%
UTour Group (SZSE:002707)	23%	33.1%

Click here to see the full list of 365 stocks from our Fast Growing Chinese Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Shanghai Aohua Photoelectricity Endoscope (SHSE:688212)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is a medical device company that specializes in the research, development, manufacturing, and sales of electronic endoscopic equipment and consumables, operating both in China and internationally with a market capitalization of approximately CN¥5.86 billion.

Operations: The company generates CN¥721.89 million from its diagnostic kits and equipment segment.

Insider Ownership: 32.2%

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. experienced a significant revenue increase to CNY 169.3 million in Q1 2024, though net income dropped to CNY 2.76 million from CNY 16.55 million year-over-year. Despite the recent dip in earnings, analysts predict a strong growth trajectory with earnings expected to rise by 55.12% annually and revenue forecasted to grow at 27.4% per year, outpacing the broader Chinese market's growth rates in both metrics.

• Unlock comprehensive insights into our analysis of Shanghai Aohua Photoelectricity Endoscope stock in this growth report.
• Our expertly prepared valuation report Shanghai Aohua Photoelectricity Endoscope implies its share price may be too high.

Circuit Fabology Microelectronics EquipmentLtd (SHSE:688630)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Circuit Fabology Microelectronics Equipment Ltd. specializes in the development and manufacturing of microelectronics equipment, with a market capitalization of approximately CN¥7.53 billion.

Operations: The company generates its revenue from the development and manufacturing of microelectronics equipment.

Insider Ownership: 29.7%

Circuit Fabology Microelectronics Equipment Ltd. reported a robust first quarter in 2024, with revenue increasing to CNY 198.05 million from CNY 156.86 million the previous year, and net income rising to CNY 39.76 million from CNY 33.51 million. Despite a lower than average industry Price-to-Earnings ratio of 40.6x and shareholder dilution last year, earnings are expected to grow by a significant margin annually over the next three years, outpacing both its past performance and market averages in China.

• Get an in-depth perspective on Circuit Fabology Microelectronics EquipmentLtd's performance by reading our analyst estimates report here.
• The analysis detailed in our Circuit Fabology Microelectronics EquipmentLtd valuation report hints at an inflated share price compared to its estimated value.

Guangzhou Great Power Energy and Technology (SZSE:300438)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Guangzhou Great Power Energy and Technology Co., Ltd focuses on researching, developing, producing, and selling a variety of batteries in China, with a market capitalization of approximately CN¥9.21 billion.

Operations: The company generates its revenue primarily from the research, development, production, and sale of various batteries within China.

Insider Ownership: 34.5%

Guangzhou Great Power Energy and Technology, a player in the battery storage sector since 2001, has seen a notable decrease in financial performance with sales dropping to CNY 6.93 billion in 2023 from CNY 9.07 billion the previous year and net income falling significantly to CNY 43.1 million from CNY 628.38 million. Despite these challenges, the company is forging ahead with strategic alliances like that with Nuvve Holding Corp., aimed at enhancing its product offerings and market reach through integrated energy solutions which could potentially revive its financial standing and market position if successfully executed by Q3 2024.

• Dive into the specifics of Guangzhou Great Power Energy and Technology here with our thorough growth forecast report.
• Our comprehensive valuation report raises the possibility that Guangzhou Great Power Energy and Technology is priced higher than what may be justified by its financials.

Turning Ideas Into Actions

• Access the full spectrum of 365 Fast Growing Chinese Companies With High Insider Ownership by clicking on this link.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com